CEO & President
Eagle Analytical
Houston, Texas, United States
Dr. Ross Caputo is the President and CEO of Eagle Analytical, an FDA-registered, A2LA ISO 17025 accredited laboratory providing analytical and microbiological testing services along with expert consulting services to 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies.
He earned his PhD in Microbiological Physiology and Immunology from Miami University in 1976, and has over 30 years of experience in the FDA-regulated pharmaceutical industry on sterilization research and aseptic processing focusing on process optimization and control.
He has authored more than 50 publications and owns 15 patents, all related to infection control, sterilization processes and the production of sterile product.
Throughout his career, Dr. Caputo has been an active participant and committee member of organizations such as AAMI/ISO and PDA, which are charged with the development of standards for the regulated marketplace.
View a list of Dr. Caputo’s publications at: eagleanalytical.com/ross/
Disclosure(s): No financial relationships to disclose
Understanding and Evaluating 503B Compounding Pharmacies
Monday, March 25, 2024
9:45 AM – 10:45 AM East Coast USA Time